Table 2. Comparison of Kidney Transplant Characteristics Between the two Groups With and Without Cytomegalovirus Infection After Renal Transplantation^a.

	CMV + (No= 104 )	CMV - (No = 96)	P
Cratinine, mg/dL	1.78 ± 1.27	1.76 ± 1.30	.933b
Transplant source			.001c,d
Living donor	36 (35)	57 (59)
Deceased donor	67 (65)	39 (41)
Previous transplantation	4 (4)	9 (9)	.117d
ATG therapy	36 (35)	29 (30)	.476d
Corticosteroid pulse therapy	9 (9)	13 (14)	.280d

Abbreviations: CMV, cytomegalovirus; PCKD: polycystic kidney disease.

^aData are presented as mean ± SD or No. (%).

^bIndependent sample t-test.

^cStatistically significant.

^dChi square test.